---
title: Anthea Pharma vs JYMed Peptide
slug_a: antheapharma
slug_b: jymedtech
site: cdmo
review_signal_gate: closed
canonical_path: /compare/antheapharma/jymedtech
generated_by: BioBM Editorial AI
---

# Anthea Pharma vs JYMed Peptide

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Anthea Pharma (antheapharma) is listed for both. Anthea Pharma is an injectable CDMO in Hyderabad, India, offering development and manufacturing of vials, emulsions, lyophilized vials, and prefilled syringes. The company highlights aseptic fill and finish, terminal sterilization, lyophilization, and formulation and analytical development for clients.

Services: 9. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

JYMed Peptide (jymedtech) is listed for cdmo. Peptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site.

Services: 12. Modalities: 1. Indications: 0. Locations: 4. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (12).

Review summary: Review summary withheld until site-level review gate opens.